Replies to post #280981 on NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Depends on the survival benefit.

As I wrote yesterday:
A major advance in the treatment of an intractable cancer will cover many sins.

To mix metaphors, a major advance against an intractable cancer will be a tank against pea shooter arguments like this.

If the data isn’t there, well, you can figure it out.

[biosectinvestor]

With a 15 times multiple, that Dendreon revenue stream would be around a $5.5 billion company. Not bad.